IQVIA Holdings Inc.
0JDM.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$44.02B
Close$
$112.42
57% downside
Current Fair Value
57% downsideOvervalued by 57% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $44.02 Billion |
|---|---|
| Enterprise Value | $60.81 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $7.92 |
| Beta | 1.18 |
| Outstanding Shares | 166,100,000 |
Return
| Return on Equity | 22.28% |
|---|---|
| Return on Assets | 4.60% |
| Return on Invested Capital | 11.10% |
Valuation & Multiples
| P/E Ratio | 31.97 |
|---|---|
| PEG | -850.28 |
| Price to Sales | 2.56 |
| Price to Book Ratio | 7.07 |
| Enterprise Value to Revenue | 3.58 |
| Enterprise Value to EBIT | 26 |
| Enterprise Value to Net Income | 44 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 3.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 28, 2026
EPS Estimate
$3.03
Average shareholder expectationRevenue Estimate
$4.30 B
Average shareholder expectationNext Earnings Call
Expected Date
October 27, 2026
EPS Estimate
$3.25
Average shareholder expectationRevenue Estimate
$4.37 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About IQVIA Holdings Inc
93,000 employees
CEO: Ari Bousbib IQVIA Holdings Inc. is a global leader empowering the life sciences sector with advanced analytics, innovative technology solutions, and comprehensive clinical research services. Operating across the Americas, Europe, Africa, and the Asi...